// Powered by Mass Cytometry - Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Rahim et al. show that immune checkpoint blockade activates CD8 T cell differentiation and proliferation in the lymph node, not within the tumor microenvironment, and these cells can be detected in transit via blood profiling.
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes - ScienceDirect
Nanoparticle-Based Immunotherapy for Cancer
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors
Dynamics and specificities of T cells in cancer immunotherapy
Put me in, coach! Peripheral T cells are ready to play
Physiology of chemokines in the cancer microenvironment
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk
CD8+ T cell differentiation and dysfunction in cancer
Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma - Laboratory Investigation
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy